Incubate Submits Comment To CMS Regarding Its Draft Guidance For The Medicare Drug Price Negotiation ProgramIncubate CoalitionApr 16, 20231 min readUpdated: Jul 15, 2024Incubate submitted our feedback to the Centers for Medicare & Medicaid Services regarding its draft guidance for the Medicare Drug Price Negotiation Program.Incubate-CMS-Comment-Medicare-Drug-Price-Negotiation-Program-Guidance.pdfDownload PDF • 116KB
Incubate Launches Life Sciences Rare Disease Tracker to Measure Research Setbacks Tied to U.S. Policy Environment
Thomas Kaiser Talks Pill Penalty, North Carolina, and the Realities of Drug Development on Making Medicine
Comments